FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074894 [Registered on: 08/10/2024] Trial Registered Prospectively
Last Modified On: 04/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Treatment for Enlarged Prostate 
Scientific Title of Study   A Comparative Clinical Study to Evaluate The Efficacy of Shilobidadi Tailam Uttarabasti and Shilobidadi Tailam Matrabasti Followed by Shilodbidadi Kashayam in the Managment of Vatastila with special refference to Benign Prostatic Hyperplasia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrMADHUSUDAN REDDY 
Designation  PANCHAKARMA POST GRADUATION 
Affiliation  Taranath goverment ayurvedic medical college and hospital,bellary.583101 
Address  Taranath government ayurvedic medical college and hospital Panchakarma OPD Room number - 06 ballari

Bellary
KARNATAKA
583101
India 
Phone  7019139480  
Fax  260273  
Email  madhusudanreddynagwar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrRAJESH SUGUR 
Designation  MD(ayu) PROFESSOR AND HOD DEPARTMENT OF PANCHAKARMA 
Affiliation  Taranath goverment ayurvedic medical college and hospital,bellary.583101 
Address  Taranath government ayurvedic medical college and hospital Panchakarma OPD Room number - 06 ballari

Bellary
KARNATAKA
583101
India 
Phone  9844457833  
Fax  260270  
Email  vdrsugur@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrRAJESH SUGUR 
Designation  MD(ayu) PROFESSOR AND HOD DEPARTMENT OF PANCHAKARMA 
Affiliation  Taranath goverment ayurvedic medical college and hospital,bellary.583101 
Address  Taranath government ayurvedic medical college and hospital Panchakarma OPD Room number - 06 ballari

Bellary
KARNATAKA
583101
India 
Phone  9844457833  
Fax  260270  
Email  vdrsugur@gmail.com  
 
Source of Monetary or Material Support  
Pharmacy Section of Taranath Government Ayurvedic Medical College And Hospital. College building Ballari 583101 
 
Primary Sponsor  
Name  DrMADHUSUDAN REDDY 
Address  Taranath government ayurvedic medical college and hospital Panchakarma OPD Room number - 06 Ballari 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrMADHUSUDAN REDDY  Taranath Goverment Ayurvedic Medical College and Hospital Bellary 583101  Taranath government ayurvedic medical college and hospital Hospital block, Panchakarma OPD Room number - 06 Ballari
Bellary
KARNATAKA 
7019139480
260273
madhusudanreddynagwar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
TGAMCIEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N398||Other specified disorders of urinary system. Ayurveda Condition: VATASHTHILA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: CHARAK SIDDHISTHANA , Procedure details: MATRA BASTI WITH SHILODBIDADI TAILA 72 ML FOR 16 DAYS )
(1) Medicine Name: SHILODBIDADI KASHAYAM, Reference: BHAISHEJYA RATNAVALI, Route: Oral, Dosage Form: Kwatha/Kashaya, Dose: 15(ml), Frequency: bd, Duration: 20 Days
2Intervention ArmProcedure-uttara-bastiH, उत्तर-बस्तिः (Procedure Reference: CHARAKA SIDDISTHANA , Procedure details: UTTARA BASTI WITH SHILODBIDADI TAILA 45 ML ADDMINISTERED UNDER A SEPTIC MEASURES FOR 9 DAYS WITH A GAP OF THREE DAYS FOR EVERY THREE DAYS)
(1) Medicine Name: SHILODBIDADI KASHAYAM, Reference: BHAISHAJYA RATNAVALI, Route: Oral, Dosage Form: Kwatha/Kashaya, Dose: 15(ml), Frequency: bd, Duration: 20 Days
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  60.00 Year(s)
Gender  Male 
Details  Patient presenting clinical features of vatastila
Patient diagnosed with bph grade 1,grade 2 and grade 3
Patient having score mild to moderate in international prostate symptoms score will be included
Patient fit for basti karma
 
 
ExclusionCriteria 
Details  Patient having ca of prostate,uti,urethral stricture,hematurie,uremia,renal failure
Patient having major systemic illeness like tb,uncontrolled diabetis mellitus
Patients with acute retention of urine who need surgical intervention
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief from subjective parameters like pain in urinary bladder and difficulty in micturation,within 10 to 12 weeks  Relief from subjective parameters like pain in urinary bladder and difficulty in micturation
within 10 to 12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in the size reduction of prostate
Improvement in post voidal residual urine volume via usg
 
42 DAYS 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="12" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Benign Prostate Hyperplasia (BPH) is a benign enlargement of prostate which occurs after 50  years. Usually between 60 and 70 years with age testosterone level drops slowly, but fall of estrogen level is not equal. The prostate enlarges through intermediate peptide growth factor, so that increases pressure on the urethra and results in urinary symptoms, such as increased frequency of micturition, Dysuria and urgency. Prevalence of BPH shows 20% in men aged 41–50yrs, 50% in men aged 51–60yrs and >90% in men older than 80yrs. At age 55yrs, approx. 25% of men report obstructive voiding symptoms, at the age of 75yrs, 50% of men complain of a decrease in the force of their urinary  stream
Hence It is the need of the hour to  understand BPH in terms of Ayurveda, so that an uncomplicated and patient friendly treatment can be  advised to the patients. Thus, Shilodbidadi tailam Uttara Basti & Matra Basti followed by Shilodbidadi Kashayam as a shamana aushadhi in both groups are adviced. Keeping all these facts in  mind,“A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF  SHILODBIDADI TAILAM UTTARABASTI AND SHILODBIDADI TAILAM MATRABASTI, FOLLOWED BY SHILODBIDADI KASHAYAM IN THE MANAGEMENT OF  VATASTHILA WITH SPECIAL REFERENCE TO BENIGN PROSTATIC HYPERPLASIA” is undertaken.
 
Close